The incidence of candidemia in healthcare centers is associated with high morbidity and mortality. Frequency varies significantly among regions, with some species being more prevalent than others in Latin America. In this study, 191 clinical Candida isolates were collected from a major hospital in Ecuador from January 2019 to February 2020 aiming to assess their prevalence and distribution. After data processing, 168 isolates characterized by the VITEK 2 system were subsequently identified by ITS sequencing. Results showed diverse Candida species distributions, with C. albicans and C. tropicalis being the most prevalent across different clinical sources. In hospitalized individuals, C. tropicalis (38%) and C. albicans (37%) were the most prevalent, followed by, C. parapsilosis (16%), C. glabrata (5%), and other non-Candida albicans (NCA) species (6%). Conversely, C. parapsilosis (48%), C. albicans (20%), and C. glabrata (14%), associated with candidemia, were the most common in blood and CSF. Additionally, uncommon NCA species such as C. haemulonii, C. kefyr, and C. pelliculosa were identified in Ecuador for the first time. Discrepancies in species identification were observed between the VITEK 2 system and ITS sequencing, coinciding at 85%. This highlights the need for ongoing surveillance and identification efforts in Ecuador’s clinical and epidemiological settings.

The COVID-19 pandemic poses a significant global health threat, characterized by high morbidity, severity, and the emergence of concerning variants. Latin America has been greatly affected, with high infection and mortality rates. Vaccination plays a crucial role in mitigating severe disease and controlling the pandemic. This study aims to assess the effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 severe acute respiratory infections (SARI) in hospitalized vaccination target groups in Ecuador. This is a test-negative design study. We used data reported through sentinel surveillance of SARI between May 2021 and March 2022 in Ecuador. Patients with case criteria of SARI and hospitalized for a minimum of 24 hours were included in the study. Cases were defined as patients with SARI with a positive RT-qPCR test for SARS-CoV-2 and controls were those with a negative result. Information on vaccination status was obtained from the national vaccination registry, a valid dose of vaccination was considered when it was administered at least 14 days prior to symptom onset. Vaccine effectiveness (VE) (1-OR/OR) was calculated using a logistic regression. A total of 1,277 patients were included in the analysis of VE. The adjusted vaccine effectiveness (aVE) in preventing hospitalization, adjusted for sex, age group, presence of one or more comorbidities, and period of the predominance of the omicron variant, was 44.5% for the partial primary schedule, 74.7% for the complete primary schedule, and 79.9% for the complete primary schedule plus booster doses. The aVE in avoiding ICU admissions was close to 80% with both the complete primary schedule and the booster doses, and in avoiding deaths, the aVE was 89% and 98%, respectively. In Ecuador, COVID-19 vaccination prevents hospitalizations, ICU admissions, and deaths. The effectiveness of the vaccines improves with more doses, offering increased protection across all age groups.

In Ecuador, the highest number of daily infections due to SARS-CoV-2 occurred in Guayaquil between April 4th and May 3th. The objective of this study is to perform a descriptive analysis of the quantitative PCR tests in real-time in Samborondón, Daule, and Durán during the months of April to August in the UEESBiolab laboratory. The results according to gender indicated that men register a greater number of positive cases compared to the female gender. People with an age within the Economically Active Population (EAP) were the ones who attended the test the most and who were positive in 13.9%. Additionally, for positive results, it was found that there is no statistically significant difference between groups for variables gender, age, canton, and parish. Finally, an increase in positive patients is observed in rural areas during this first wave of infection, with the rural population of Samborondón with the highest number of infections. En Ecuador, el mayor número de contagios diarios por SARS-CoV-2 ocurrió en Guayaquil entre el 4 de abril al 3 de mayo. Este estudio, tiene como objetivo realizar un análisis descriptivo de las pruebas PCR cuantitativa en tiempo real en las parroquias de Samborondón, Daule y Durán durante los meses de abril a agosto en el laboratorio UEESBiolab. Los resultados en función del género indicaron que, los hombres registran un mayor número de casos positivos en comparación al género femenino. Las personas con una edad dentro de la Población Económicamente Activa (PEA) fueron los que más acudieron a realizarse la prueba y que resultaron positivos en un 13,9 %. Adicionalmente, para los resultados positivos se comprobó que no existe diferencia estadística significativa entre grupos para variables género, edad, cantón y parroquia. Finalmente, se observa un incremento de los pacientes positivos en zonas rurales durante esta primera ola de infección, siendo con mayor número de contagios la población rural de Samborondón.